{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:47:40Z","timestamp":1792464460807,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.aohep.2024.101511","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T09:16:33Z","timestamp":1714986993000},"page":"101511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Luis","family":"Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Simian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham I.","family":"Gajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Urra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ximo","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Roblero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-8844","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Urz\u00faa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Poniachik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.aohep.2024.101511_bib0001","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101511_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01823.x","article-title":"Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics","volume":"29","author":"Riquelme","year":"2009","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.aohep.2024.101511_bib0003","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4067\/s0034-98872019000901114","article-title":"Increasing frequency of obesity in Chile","volume":"147","author":"Vio","year":"2019","journal-title":"Rev Med Chil"},{"issue":"1","key":"10.1016\/j.aohep.2024.101511_bib0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clinre.2016.07.005","article-title":"Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases","volume":"41","author":"Motamed","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101511_bib0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MEG.0000000000000286","article-title":"Association between liver fibrosis and coronary heart disease risk in patients with non-alcoholic fatty liver disease","volume":"27","author":"Dogan","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101511_bib0006","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"argher","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101511_bib0007","doi-asserted-by":"crossref","first-page":"33386","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep."},{"key":"10.1016\/j.aohep.2024.101511_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.711484","article-title":"Non-alcoholic fatty liver disease, liver fibrosis and cardiovascular disease in the adult US population","volume":"12","author":"Ciardullo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.aohep.2024.101511_bib0009","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: the framingham heart study","volume":"73","author":"Long","year":"2021","journal-title":"Hepatology"},{"issue":"38","key":"10.1016\/j.aohep.2024.101511_bib0010","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.3748\/wjg.v19.i38.6453","article-title":"Non-alcoholic fatty liver disease is associated with coronary artery disease in Koreans","volume":"19","author":"Choi","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101511_bib0011","doi-asserted-by":"crossref","first-page":"9C","DOI":"10.1016\/S0002-9149(99)80390-7","article-title":"Bypass Angioplasty Revascularization Investigation (BARI): baseline clinical and angiographic data","volume":"75","author":"Rogers","year":"1995","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101511_bib0012","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with non-alcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"30","key":"10.1016\/j.aohep.2024.101511_bib0013","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2024.101511_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.934225","article-title":"Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: a meta-analysis","volume":"13","author":"Wen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.aohep.2024.101511_bib0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening","volume":"44","author":"Lomonaco","year":"2021","journal-title":"Diabetes Care"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T12:46:22Z","timestamp":1719492382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124003053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1665268124003053"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101511","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C.","name":"copyright","label":"Copyright"}],"article-number":"101511"}}